Results 231 to 240 of about 337,050 (372)
Complexity of tumor vasculature in clear cell renal cell carcinoma [PDF]
Chao‐Nan Qian+3 more
openalex +1 more source
This study identifies LncDARS‐AS1 as a novel oncogenic regulator that stabilizes ATP1A1 and enhances Na⁺/K⁺ ATPase activity, promoting osteosarcoma metastasis. Targeting the LncDARS‐AS1/ATP1A1/NKA axis, including pharmacological inhibition with digoxin, offers promising opportunities for the development of new therapeutic strategies against ...
Mingxian Xu+12 more
wiley +1 more source
Cytogenetic Profile Predicts Prognosis of Patients With Clear Cell Renal Cell Carcinoma [PDF]
Tobias Klatte+9 more
openalex +1 more source
STK25 Loss Augments Anti‐PD‐1 Therapy Efficacy by Regulating PD‐L1 Stability in Colorectal Cancer
This study demonstrates that STK25 depletion facilitates CRC immune escape through the inhibition of PD‐L1 Ser283 phosphorylation‐mediated ubiquitination, and promotes tumor growth. Furthermore, these findings identify STK25 as a potential therapeutic target to trigger antitumor immunity and promote immunotherapy efficacy. Abstract Tumor immune evasion
Xiaowen Qiao+20 more
wiley +1 more source
Immune Checkpoint Inhibitors in Clear Cell Renal Cell Carcinoma (ccRCC). [PDF]
Rysz J+3 more
europepmc +1 more source
The PTEN regulator DJ‐1 is associated with hTERT expression in clear cell renal cell carcinoma [PDF]
Raviprakash T. Sitaram+6 more
openalex +1 more source
The role of splicing factor 3A subunit 3 (SF3A3) in driving endometrial cancer (EC) progression and potential therapeutic interventions. SF3A3, a core component of the U2 small nuclear ribonucleoprotein (U2 snRNP), is upregulated in endometrial cancer (EC) and promotes tumor growth and cisplatin resistance. RNA‐binding protein immunoprecipitation (RIP)
Wei Yu+13 more
wiley +1 more source
Proteomics and succinylation modification characterization in clear cell renal cell carcinoma. [PDF]
Yue D, Zheng M.
europepmc +1 more source
Methylation level of the RASSF1A promoter is an independent prognostic factor for clear-cell renal cell carcinoma [PDF]
Yosuke Kawai+8 more
openalex +1 more source
Inducing ferroptosis is a promising strategy for combating tumor resistance. Upregulated PIP5K1A competes with NRF2 for KEAP1 binding, which decreases the ubiquitination degradation of NRF2 and promotes its nuclear translocation, thereby suppressing ferroptosis, and ultimately driving hepatocellular carcinoma (HCC) tumorigeneses and sorafenib ...
Mengzhou Guo+9 more
wiley +1 more source